
1. parasitology. 2019 nov;146(13):1646-1654. doi: 10.1017/s0031182019001161. epub
2019 sep 13.

ron2, novel gene babesia bigemina, contains conserved, immunodominant b-cell
epitopes induce antibodies block merozoite invasion.

mosqueda j(1), hidalgo-ruiz m(1), calvo-olvera da(1), hernandez-silva dj(1), ueti
mw(2), mercado-uriostegui ma(1), rodriguez a(3), ramos-aragon ja(4),
hernandez-ortiz r(4), kawazu si(5), igarashi i(5).

author information: 
(1)immunology vaccines laboratory. facultad de ciencias naturales,
universidad autónoma de querétaro, querétaro, qro, mexico.
(2)u. s. department agriculture, animal disease research unit, agricultural
research service, pullman, wa, 99164, usa.
(3)facultad de ciencias naturales, universidad autónoma de querétaro, querétaro, 
qro, mexico.
(4)cenid-parasitologia-inifap, morelos, mexico.
(5)national research center protozoan diseases, obihiro university of
agriculture veterinary medicine, inada, obihiro, japan.

bovine babesiosis important protozoan disease transmitted ticks.
in plasmodium falciparum, another apicomplexa protozoan, interaction of
rhoptry neck protein 2 (ron2) apical membrane antigen-1 (ama-1) been
described key role invasion process. date, ron2 
described babesia bigemina, causal agent bovine babesiosis the
americas. work, found ron2 gene b. bigemina genome. ron2
encodes protein 1351 amino acids long, identity 64% (98%
coverage) ron2 b. bovis contains clag domain, conserved domain 
in apicomplexa. b. bigemina ron2 single copy gene transcribed 
expressed blood stages determined rt-pcr, western blot, confocal
microscopy. serum samples b. bigemina-infected bovines screened the
presence ron2-specific antibodies, showing recognition conserved b-cell
epitopes. importantly, vitro neutralization assays showed inhibitory effect
of ron2-specific antibodies red blood cell invasion b. bigemina.
therefore, ron2 novel antigen b. bigemina contains conserved b-cell
epitopes, induce antibodies inhibit merozoite invasion.

doi: 10.1017/s0031182019001161 
pmcid: pmc6786967
pmid: 31452491  [indexed medline]

